As of November 6, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of Yubo International Biotech Limited. The largest reported stake is Flydragon International Ltd's, at 48.1%. 2 filings are on record since July 25, 2025 (Schedule 13D/A, July 25, 2025).
Sell to companies like Yubo International Biotech Limited? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Yubo International Biotech Limited has 2 Schedule 13D or 13G filings on record since 2025-07-25. 2 holders' latest filing reports 5% or more of class a common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Flydragon International Ltd | 48.1% | 81,943,800 | SCHEDULE 13D/A, 2025-07-25 | 2025-07-23 |
| Chinaone Technology Ltd | 15.1% | 25,811,400 | SCHEDULE 13D/A, 2025-07-25 | 2025-07-23 |
Holding shares or following this stake? See who's behind Yubo International Biotech Limited and the warning signs.
Free to see. No signup.
Watch Yubo International Biotech Limited
Get an email when Yubo International Biotech Limited files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Yubo International Biotech Limited?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Yubo International Biotech Limited: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Yubo International Biotech Limited covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
2 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Flydragon International Ltd | 0 | 81,943,800 | 0 | 81,943,800 | SCHEDULE 13D/A, 2025-07-25 |
| Jun Wang | 81,943,800 | 0 | 81,943,800 | 0 | SCHEDULE 13D/A, 2025-07-25 |
| Chinaone Technology Ltd | 0 | 25,811,400 | 0 | 25,811,400 | SCHEDULE 13D/A, 2025-07-25 |
| Yang Wang | 25,811,400 | 0 | 25,811,400 | 0 | SCHEDULE 13D/A, 2025-07-25 |
The latest filing identifies Yubo International Biotech Limited by CUSIP 988366100 and gives its principal executive office as 1102, 11th Floor, Building 2, No.10, Chaoyang Park S. Rd., Chaoyang District, BEIJING (SCHEDULE 13D/A, 2025-07-25).
Source of funds (Item 3)
Item 3 of the Schedule 13D is hereby supplemented by the addition of the following information: Securities Purchase Agreement On July 23, 2025, the Issuer entered into a Securities Purchase Agreement, by and among the Issuer, on the one hand, and FlyDragon and Chinaone Technology Limited, a British Virgin Islands limited liability company ("Chinaone"), on the other hand, for a sale of an aggregate of 50,600,000 shares of Class A Common Stock (the "Transaction").Flydragon International Ltd, SCHEDULE 13D/A, 2025-07-25
Item 3 of the Schedule 13D is hereby supplemented by the addition of the following information: Securities Purchase Agreement On July 23, 2025, the Issuer entered into a Securities Purchase Agreement, by and among the Issuer, on the one hand, and FlyDragon International Limited, a British Virgin Islands limited liability company ("FlyDragon"), and Chinaone, on the other hand, for a sale of an aggregate of 50,600,000 shares of Class A Common Stock (the "Transaction").Chinaone Technology Ltd, SCHEDULE 13D/A, 2025-07-25
Purpose of Transaction (Item 4)
Flydragon International Ltd
Item 4 of the Schedule 13D is hereby supplemented by the addition of the following information: Securities Purchase Agreement The subsection entitled "Securities Purchase Agreement" under Item 3 above is hereby incorporated by reference.Item 4 of the SCHEDULE 13D/A filed 2025-07-25
Chinaone Technology Ltd
Item 4 of the Schedule 13D is hereby supplemented by the addition of the following information: Securities Purchase Agreement The subsection entitled "Securities Purchase Agreement" under Item 3 above is hereby incorporated by reference.Item 4 of the SCHEDULE 13D/A filed 2025-07-25
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-25 | Flydragon International Ltd | 48.1% | SCHEDULE 13D/A |
| 2025-07-25 | Chinaone Technology Ltd | 15.1% | SCHEDULE 13D/A |
Questions about who owns Yubo International Biotech Limited
Who owns Yubo International Biotech Limited?
On this page, 2 holders' latest ownership filings report 5% or more of Yubo International Biotech Limited: Flydragon International Ltd (48.1%, Schedule 13D/A, filed 2025-07-25) and Chinaone Technology Ltd (15.1%, Schedule 13D/A, filed 2025-07-25).
Who are the largest shareholders of Yubo International Biotech Limited?
By the share each holder's latest filing reports, the largest holders of Yubo International Biotech Limited on this page are Flydragon International Ltd (48.1%) and Chinaone Technology Ltd (15.1%).
When did Flydragon International Ltd buy into Yubo International Biotech Limited?
The filings give report dates, not purchase dates. The earliest filing from Flydragon International Ltd on this page is the Schedule 13D/A, filed 2025-07-25, reporting 48.1%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 2 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Yubo International Biotech Limited. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.